These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Sullivan PW; Nair KV; Patel BV Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556 [TBL] [Abstract][Full Text] [Related]
3. Desloratadine for allergic rhinitis. See S Am Fam Physician; 2003 Nov; 68(10):2015-6. PubMed ID: 14655812 [No Abstract] [Full Text] [Related]
4. Allergic rhinitis: market evolution. Clark MJ; Million RP Nat Rev Drug Discov; 2009 Apr; 8(4):271-2. PubMed ID: 19337269 [No Abstract] [Full Text] [Related]
6. Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US. Sullivan PW BMJ; 2005 Apr; 330(7496):904-5. PubMed ID: 15831881 [No Abstract] [Full Text] [Related]
7. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Sullivan PW; Follin SL; Nichol MB Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671 [TBL] [Abstract][Full Text] [Related]
8. South Dakota Medicaid will now cover OTC Loratadine and OTC Prilosec. Brandenburg V; Darger D; Christianson H; Goeden G; Engelbrecht J; Hedge D; Holm R; Ladwig W; S D J Med; 2005 Jan; 58(1):17. PubMed ID: 15696732 [No Abstract] [Full Text] [Related]
9. Marketing of a new non-sedating antihistamine (fexofenadine) puts an additional burden on healthcare system resources in Israel. Cohen AD; Vardy DA; Gan-El U; Lieberman N; Reuvni H Eur J Gen Pract; 2006; 12(2):77-9. PubMed ID: 16945882 [No Abstract] [Full Text] [Related]
10. FDA approves OTC Claritin. FDA Consum; 2003; 37(1):3. PubMed ID: 12625285 [No Abstract] [Full Text] [Related]
11. OTC loratadine. Med Lett Drugs Ther; 2003 Jan; 45(1147):3-4. PubMed ID: 12515952 [No Abstract] [Full Text] [Related]
12. Access to allergy care: implications for quality healthcare and public safety. Berger WE; Rosenwasser L; Atwater JS Manag Care Q; 2003; 11(2):8-11. PubMed ID: 12968437 [TBL] [Abstract][Full Text] [Related]
13. Promotion of OTC products within a network-model HMO. Gilderman A; Shinmoto M; Andrews S Med Interface; 1996 Jun; 9(6):104-8. PubMed ID: 10157923 [TBL] [Abstract][Full Text] [Related]
14. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines. Sullivan PW; Nichol MB Value Health; 2004; 7(4):402-12. PubMed ID: 15449632 [TBL] [Abstract][Full Text] [Related]
15. The Claritin case: how one firm played the patent game. Novak V Time; 1999 Nov; 154(21):42. PubMed ID: 10622840 [No Abstract] [Full Text] [Related]
16. Ugly wait at the counter. Insurer pushes to make allergy drugs nonprescription. Benko LB Mod Healthc; 2001 Aug; 31(32):22-3. PubMed ID: 11507861 [No Abstract] [Full Text] [Related]
17. Pre and post treatment mucociliary function in allergic rhinitis in three different treatment modalities. Lee LM; Gendeh BS Med J Malaysia; 2003 Mar; 58(1):17-20. PubMed ID: 14556322 [TBL] [Abstract][Full Text] [Related]
18. [Respiratory allergies in the child and the adult]. Magnan A Rev Prat; 2004 Jan; 54(2):189-98. PubMed ID: 15086062 [No Abstract] [Full Text] [Related]
19. Potential of levocetirizine in the relief of nasal congestion. Klimek L Int J Clin Pract; 2005 Jun; 59(6):721-9. PubMed ID: 15924602 [TBL] [Abstract][Full Text] [Related]
20. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. Spencer HM Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546 [No Abstract] [Full Text] [Related] [Next] [New Search]